TORONTO, Dec. 3, 2015 /CNW/ - Bedrocan Canada Inc. (Bedrocan), wholly owned subsidiary of Canopy Growth Corporation ("Canopy Growth" or "the Company") (TSX.V: CGC) is pleased to announce that it has received a license renewal for its shipping and storage facility in the Greater Toronto Area.
The license extension is valid for one calendar year from the date of issuance, December 2nd, 2015 and will allow Bedrocan to store and sell up to 240kg of dried cannabis during the licensing period. Bedrocan also holds a separate 2000kg production license that is valid through February 17th, 2016.
"We are pleased to have met the necessary regulatory requirements to extend this sales and storage license," said Marc Wayne, President of Bedrocan. "It is a strategically located facility which can ship quickly and easily to the most densely-populated region in the country so it is good news for our customers as well."
This is the smallest of the four Marihuana for Medical Purposes Regulations (MMPR) licenses held by the Company, which is approved to produce and sell a total of 5740kg of dried cannabis products through its various licenses, the highest total in the industry. Bedrocan holds a separate production and sales license allowing it to grow, store, and sell up to 2000 kg of cannabis. Tweed Farms is licensed to grow cannabis plants in its 350,000 sq. ft. greenhouse. Tweed Inc. is licensed to grow, store, and sell 3500kg of dried cannabis. In total, Canopy Growth operates more than 550,000 sq. ft. of cannabis production space.
About Bedrocan Canada
Bedrocan Canada is focused on medicinal cannabis production and research, including, the EQUAL Study, which is currently enrolling patients and evaluating how cannabis is affecting their quality of life of Canadian patients. Bedrocan's standardized strains have been used by thousands of patients in seven countries around the world. www.bedrocan.ca
About Canopy Growth Corporation
Canopy Growth is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with dual licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Tweed Farms, and Bedrocan Canada, the Company operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions. The Company is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, conducting robust clinical research, and furthering the public's understanding of how marijuana is used for medical purposes. www.canopygrowth.com
The license extension is valid for one calendar year from the date of issuance, December 2nd, 2015 and will allow Bedrocan to store and sell up to 240kg of dried cannabis during the licensing period. Bedrocan also holds a separate 2000kg production license that is valid through February 17th, 2016.
"We are pleased to have met the necessary regulatory requirements to extend this sales and storage license," said Marc Wayne, President of Bedrocan. "It is a strategically located facility which can ship quickly and easily to the most densely-populated region in the country so it is good news for our customers as well."
This is the smallest of the four Marihuana for Medical Purposes Regulations (MMPR) licenses held by the Company, which is approved to produce and sell a total of 5740kg of dried cannabis products through its various licenses, the highest total in the industry. Bedrocan holds a separate production and sales license allowing it to grow, store, and sell up to 2000 kg of cannabis. Tweed Farms is licensed to grow cannabis plants in its 350,000 sq. ft. greenhouse. Tweed Inc. is licensed to grow, store, and sell 3500kg of dried cannabis. In total, Canopy Growth operates more than 550,000 sq. ft. of cannabis production space.
About Bedrocan Canada
Bedrocan Canada is focused on medicinal cannabis production and research, including, the EQUAL Study, which is currently enrolling patients and evaluating how cannabis is affecting their quality of life of Canadian patients. Bedrocan's standardized strains have been used by thousands of patients in seven countries around the world. www.bedrocan.ca
About Canopy Growth Corporation
Canopy Growth is Canada's first publicly traded medical marijuana company and the first geographically diversified producer with dual licenses under the Marihuana for Medical Purposes Regulations. Through its wholly owned subsidiaries, Tweed, Tweed Farms, and Bedrocan Canada, the Company operates three state-of-the-art production facilities in Ontario and distributes marijuana across the country to Canadian patients managing a host of medical conditions. The Company is dedicated to educating healthcare practitioners, providing consistent access to high quality medication, conducting robust clinical research, and furthering the public's understanding of how marijuana is used for medical purposes. www.canopygrowth.com